Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

National Institute of Allergy and Infectious Diseases (NIAID) · 1998
ClinicalTrials.gov · Datasets · License: Public Domain · 1998
Open Source ↗
anti-hiv-agentscombinationdose-response-relationshipdrugdrug-therapyhiv-infections
hiv infections, injections, subcutaneous, interleukin-2, dose-response relationship, drug, drug therapy, combination, cd4 lymphocyte count, anti-hiv agents, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 813434
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.